Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00313677 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Trial Readiness for the Dystroglycanopathies

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jul 2025 to Jul 2030
    • Study completion date: Jul 2026 to Jul 2030
    • Site contact updated
    • Publications: 7 to 18
    v20
  2. Enrollment target: 175 to 190v19
  3. Enrollment target: 160 to 175v18
  4. Study description expanded, about 2 wordsv17
  5. Primary completion date: Jul 2020 to Jul 2025
    • Study completion date: Jul 2020 to Jul 2026
    v16
Show 14 earlier versionsHide 14 earlier versions
  1. Enrollment target: 120 to 160
    • Primary and study completion dates: Mar 2020 to Jul 2020
    v15
  2. Re-verified, no change to tracked fieldsv14
  3. Lead sponsor: University of Iowa to Katherine Mathewsv13
  4. Primary completion date: Mar 2015 to Mar 2020
    • Study description expanded, about 4 words
    v12
  5. 2 versions Re-verified since Jan 4, 2012, no change to tracked fieldsv10-v11
  6. Enrollment target: 100 to 120v9 Show 4 more changesShow less
    • Eligibility criteria expanded, about 13 words
    • Study description shortened, about 47 words
    • Site contact updated
    • Study title shortened, about 1 word
  7. Primary completion date: Mar 2010 to Mar 2015
    • Study completion date: Mar 2015 to Mar 2020
    v8
  8. Site contact updatedv7
  9. Re-verified, no change to tracked fieldsv6
  10. Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS) to University of Iowa
    • Primary completion date: Mar 2010
    • Study completion date: Mar 2015
    • Collaborators expanded, about 8 words
    v5
  11. 3 versions Re-verified since Oct 13, 2006, no change to tracked fieldsv2-v4
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the study is to describe the early signs and symptoms of the dystroglycanopathies, and to gather information that will be required for future clinical trials.
Trial Details
NCT Number NCT00313677
Lead Sponsor Katherine Mathews
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS)
Conditions
(from sponsor)		 Muscular Dystrophy
Related terms Muscular Dystrophies, Muscular Dystrophy, Limb-Girdle, Type 2I, Muscular Dystrophy, Limb-Girdle, Type 2M, Walker-Warburg Syndrome
Enrollment 190 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov